PrePex

PrePex is the only non-surgical medical device for adult male circumcision used as part of a comprehensive HIV prevention strategy in Sub-Saharan Africa. It has been scientifically validated that circumcised men reduce their risk of HIV infection by 60% to 70%. Based on this definitive evidence, the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) recommended in 2007 that voluntary medical male circumcision (VMMC) be offered as part of a comprehensive HIV prevention strategy in geographic areas with high prevalence of heterosexually transmitted HIV and low prevalence of male circumcision. As a result UNAIDS and WHO in partnership with The United States President’s Emergency Plan For AIDS Relief (PEPFAR), the Bill & Melinda Gates Foundation and the World Bank, announced an accelerated plan to scale up VMMC to approximately 20 million men in 13 target countries in Sub-Saharan Africa by the end of 2015, saving roughly 3.4 million lives and US$16.5 billion due to averted treatment and care. In order to provide the tools necessary to reach that goal, Circ MedTech developed the PrePex device to facilitate safe, simple, scalable and cost effective non-surgical adult male circumcision as part of a comprehensive HIV prevention plan.